Search - tctmd.com

Displaying 301 - 320 of 333

Sort: Relevancy | Date

News Daily News

Post Angiography Testosterone Therapy Increases Cardiovascular Events in High-Risk Men

December 05, 2013

Presentation

Interventional Approaches to Stroke Prevention in Atrial Fibrillation

Presenter: William A. Gray

December 02, 2013

Presentation TCT 2013

How the Cardiologist Can Help in Stroke Prevention

Presenter: Leo Nelson Hopkins

October 31, 2013

Presentation TCT 2013

Stroke Prevention During Cardioversion: Are TEEs Needed?

Presenter: Allan Klein

October 29, 2013

Presentation TCT 2013

Left Atrial Appendage Occlusion: A Valid Option to Anticoagulation for Long-term Prevention of Stroke

Presenter: Saibal Kar

October 29, 2013

News Daily News

Troponin T Improves Clinical Stroke Risk Assessment in A-fib Patients

October 04, 2013

News Daily News

La Troponina T Mejora la Valoración del Riesgo Clínico de sufrir ACV en Pacientes con FA

October 04, 2013

News Daily News

轻微卒中/短暂性脑缺血发作后，双联抗血小板疗法与阿司匹林相比能够减少卒中复发

July 24, 2013

News Daily News

Después de un accidente cerebrovascular menor/AIT, la terapia antiplaquetaria doble reduce el accidente cerebrovascular recurrente en comparación con la aspirina

July 24, 2013

News Daily News

After Minor Stroke/TIA, Dual Antiplatelet Therapy Reduces Recurrent Stroke vs. Aspirin

July 24, 2013

Presentation

Clopidogrel with Aspirin in Acute Minor Stroke or TIA

Presenter: Yongjun Wang

June 26, 2013

News Daily News

CREST Analysis: Stroke Uncommon After Carotid Procedures, May Be Preventable

Jason Kahn

December 02, 2012

News Daily News

Study Explores Predictors, Consequences of Stroke After TAVR

Caitlin E. Cox

November 18, 2012

Presentation TCT 2012

Novel Anticoagulants for Stroke Prevention in Patients with Atrial Fibrillation

Presenter: Jonathan Halperin

October 25, 2012

Presentation TCT 2012

Atherosclerotic Carotid Bifurcation Stenosis: Primary and Secondary Prevention Strategies

Presenter: William Gray

October 24, 2012

Presentation TCT 2012

When Does Brachiocephalic and Vertebral Disease Warrant Intervention for Stroke Prevention, and What Are the Expected Outcomes?

Presenter: Tyrone Collins

October 24, 2012

Presentation

Percutaneous LAA Closure for Stroke Prevention in A-fib Patients: An Assessment of Net Clinical Benefit

Presenter: S.R. Gangireddy

September 26, 2012

News Daily News

Apixaban Less Costly Than Aspirin for Stroke Prevention in A-Fib at 10 Years

Caitlin E. Cox

July 12, 2012

News Daily News

A los 10 Años el Apixaban resulta Más Barato que la Aspirina para la Prevención de ACV en Pacientes con FA

Caitlin E. Cox

July 12, 2012

Presentation

Cost-Effectiveness of Apixaban vs. Aspirin for Stroke Prevention Among A-fib Pts Unsuitable for Warfarin

Presenter: S. Lee

July 11, 2012

Advertisement

Post Angiography Testosterone Therapy Increases Cardiovascular Events in High-Risk Men

Interventional Approaches to Stroke Prevention in Atrial Fibrillation

How the Cardiologist Can Help in Stroke Prevention

Stroke Prevention During Cardioversion: Are TEEs Needed?

Left Atrial Appendage Occlusion: A Valid Option to Anticoagulation for Long-term Prevention of Stroke

Troponin T Improves Clinical Stroke Risk Assessment in A-fib Patients

La Troponina T Mejora la Valoración del Riesgo Clínico de sufrir ACV en Pacientes con FA

轻微卒中/短暂性脑缺血发作后，双联抗血小板疗法与阿司匹林相比能够减少卒中复发

Después de un accidente cerebrovascular menor/AIT, la terapia antiplaquetaria doble reduce el accidente cerebrovascular recurrente en comparación con la aspirina

After Minor Stroke/TIA, Dual Antiplatelet Therapy Reduces Recurrent Stroke vs. Aspirin

Clopidogrel with Aspirin in Acute Minor Stroke or TIA

CREST Analysis: Stroke Uncommon After Carotid Procedures, May Be Preventable

Study Explores Predictors, Consequences of Stroke After TAVR

Novel Anticoagulants for Stroke Prevention in Patients with Atrial Fibrillation

Atherosclerotic Carotid Bifurcation Stenosis: Primary and Secondary Prevention Strategies

When Does Brachiocephalic and Vertebral Disease Warrant Intervention for Stroke Prevention, and What Are the Expected Outcomes?

Percutaneous LAA Closure for Stroke Prevention in A-fib Patients: An Assessment of Net Clinical Benefit

Apixaban Less Costly Than Aspirin for Stroke Prevention in A-Fib at 10 Years

A los 10 Años el Apixaban resulta Más Barato que la Aspirina para la Prevención de ACV en Pacientes con FA

Cost-Effectiveness of Apixaban vs. Aspirin for Stroke Prevention Among A-fib Pts Unsuitable for Warfarin

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content